Orthopedic Implants Market By Product Type, By Biomaterial, By Type : Global Opportunity Analysis and Industry Forecast, 2022-2032

List of Tables

The global orthopedic implants market was valued at $47,190.57 million in 2022 and is estimated to reach $73,326.75 million by 2032, exhibiting a CAGR of 4.5% from 2023 to 2032.

Orthopedic implants are medical devices used to replace or support the damaged or missing bones in the body. Orthopedic implants are divided into two groups such as permanent implants and temporary implants. Permanent orthopedic implants are used for hip, knee, ankle, shoulder, elbow, wrist, and finger joints, which are present in the human body throughout the life span of an individual.

Further, temporary orthopedic implants include plates, screws, pins, wires, and intramedullary nails, which are present for shorter periods just long enough to let the bones heal. Orthopedic implants are used to treat a variety of conditions such as osteoarthritis, fractures, and spinal disorders. Orthopedic implants include joint replacements (such as hip and knee replacement), spinal fusion devices, plates and screws used to stabilize fractures. They are made of materials such as metals, plastics, ceramic, and various polymers.

The major factors driving the growth of the orthopedic implants market are increase in incidences of osteoarthritis and other degenerative diseases, technological advancements that allow more effective and long-lasting implants and rise in geriatric population. In addition, a rise in the number of sports-related injuries is also expected to drive the growth of the market.

For instance, according to report published by the National Safety Council of the U.S. 2022 stated that in 2021, 20% rise in sports and recreational injuries was observed as compared to 2020, thus a rise in number of sport related injuries is expected to drive the growth of the market. Further, geriatric population is prone to develop and diagnose orthopedicdiseases such as arthritis, dislocation of bones and fractures, thus rise in geriatric population is anticipated to drive the growth of the market.

For instance, according to an article published by American Geriatric Society 2021 stated that 60 million people in the U.S. are aged 65 years or above and 80% of these population suffer from musculoskeletal conditions, thus rise in geriatric population drives the growth of orthopedic implant market. In addition, the rise in technological innovations in orthopedic implants, rise in adoption of orthopedic implants and improvement of healthcare infrastructure in the emerging countries, further supplement the growth of orthopedic implant market.

However, the high cost associated with procedures involving orthopedic implants treatment is the factor which hampers the growth of orthopedic implants market. In addition, stringent government policies regarding implants and their procedures are also expected to restrain the growth of the market. Furthermore, the rise in demand for orthopedic implants and rise in technological advancements are the factors which offer lucrative opportunities to the key players of orthopedic implants market. The global orthopedic implants market is segmented into product, type, biomaterial, and region. On the basis of product, the market is categorized into reconstructive joint replacements, spinal implants, dental implants, trauma, orthobiologics, and others. The reconstructive joint replacements segment is segmented into knee replacement implants, hip replacement implants, and extremities that include upper extremity reconstruction and lower extremity reconstruction.

In addition, spinal implants segment is further divided into spinal fusion implants, vertebral compression fracture (VCF) devices, and motion preservation devices/non-fusion devices. Furthermore, dental implants are again classified into root form dental implants and plate form dental implants. Moreover, orthobiologics is further segmented into demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), viscosupplementation products, synthetic bone substitutes, and others.

On the basis of type, the market is classified into knee, hip, wrist & shoulder, dental, spine, ankle, and others. On the basis of biomaterial, the market is categorized into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global orthopedic implants market are: Arthrex, Inc., Colfax Corporation (DJO, LLC), CONMED CORPORATION, GLOBUS MEDICAL INC., Johnson & Johnson (DEPUY SYNTHES), Medtronic Plc, NuVasive Inc., Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet Holdings Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the orthopedic implants market analysis from 2022 to 2032 to identify the prevailing orthopedic implants market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the orthopedic implants market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global orthopedic implants market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

Reconstructive Joint Replacements
- Type
- Knee Replacement Implants
- Hip Replacement Implants
- Extremities
Type
Spinal Implants
- Type
- Spinal fusion implants
Type

Invasive Spinal bone stimulators
Vertebral Compression Fracture (VCF) Devices

Type

Motion Preservation Devices/Non-Fusion Devices

Type
Dental Implants
- Type
- Root Form Dental Implants
- Plate Form Dental Implants
Trauma
Orthobiologics
- Type
- Demineralized Bone Matrix (DBM)
- Allograft
- Bone Morphogenetic Protein (BMP)
- Viscosupplementation Products
- Synthetic Bone Substitutes
- Others
Others

By Biomaterial

Metallic Biomaterials
- Type
- Stainless steel
- Titanium Alloy
- Cobalt Alloy
- Others
Ceramic Biomaterials
Polymeric Biomaterials
Others

By Type

Wrist and Shoulder
Dental
Spine
Ankle
Others
Knee
Hip

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players

Zimmer Biomet Holdings Inc.
Arthrex, Inc.
Globus Medical, Inc.
Medtronic plc
Smith & Nephew plc
NuVasive Inc.
CONMED Corporation
Johnson & Johnson
Stryker Corporation
Colfax Corporation (DJO GLOBAL LLC)

Product Code: A01845

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. High bargaining power of buyers
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate threat of new entrants
- 3.3.5. High intensity of rivalry
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Rise in prevalence of orthopedic disorders
  - 3.4.1.2. Technological advancements in the field of orthopedic implants
  - 3.4.1.3. Surge in demand of orthopedic implants
- 3.4.2. Restraints
  - 3.4.2.1. High cost of orthopedic implant
  - 3.4.2.2. Complications with implant procedure
- 3.4.3. Opportunities
  - 3.4.3.1. Growth opportunities in emerging markets
3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Reconstructive Joint Replacements
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.2.4. Reconstructive Joint Replacements Orthopedic Implants Market by Type
  - 4.2.4.1. Extremities Orthopedic Implants Market by Type
  - 4.2.4.1.1. Upper Extremity Reconstruction Orthopedic Implants Market by Type
  - 4.2.4.1.1. Lower Extremity Reconstruction Orthopedic Implants Market by Type
4.3. Spinal Implants
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.3.4. Spinal Implants Orthopedic Implants Market by Type
  - 4.3.4.1. Spinal fusion implants Orthopedic Implants Market by Type
  - 4.3.4.2. Vertebral Compression Fracture (VCF) Devices Orthopedic Implants Market by Type
  - 4.3.4.3. Motion Preservation Devices/Non-Fusion Devices Orthopedic Implants Market by Type
4.4. Dental Implants
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- 4.4.4. Dental Implants Orthopedic Implants Market by Type
4.5. Trauma
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country
4.6. Orthobiologics
- 4.6.1. Key market trends, growth factors and opportunities
- 4.6.2. Market size and forecast, by region
- 4.6.3. Market share analysis by country
- 4.6.4. Orthobiologics Orthopedic Implants Market by Type
4.7. Others
- 4.7.1. Key market trends, growth factors and opportunities
- 4.7.2. Market size and forecast, by region
- 4.7.3. Market share analysis by country

CHAPTER 5: ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Metallic Biomaterials
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.2.4. Metallic Biomaterials Orthopedic Implants Market by Type
5.3. Ceramic Biomaterials
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Polymeric Biomaterials
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Others
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country

CHAPTER 6: ORTHOPEDIC IMPLANTS MARKET, BY TYPE

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Knee
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Hip
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Wrist and Shoulder
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
6.5. Dental
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by region
- 6.5.3. Market share analysis by country
6.6. Spine
- 6.6.1. Key market trends, growth factors and opportunities
- 6.6.2. Market size and forecast, by region
- 6.6.3. Market share analysis by country
6.7. Ankle
- 6.7.1. Key market trends, growth factors and opportunities
- 6.7.2. Market size and forecast, by region
- 6.7.3. Market share analysis by country
6.8. Others
- 6.8.1. Key market trends, growth factors and opportunities
- 6.8.2. Market size and forecast, by region
- 6.8.3. Market share analysis by country

CHAPTER 7: ORTHOPEDIC IMPLANTS MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Product Type
- 7.2.3. Market size and forecast, by Biomaterial
- 7.2.4. Market size and forecast, by Type
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Key market trends, growth factors and opportunities
  - 7.2.5.1.2. Market size and forecast, by Product Type
  - 7.2.5.1.3. Market size and forecast, by Biomaterial
  - 7.2.5.1.4. Market size and forecast, by Type
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Key market trends, growth factors and opportunities
  - 7.2.5.2.2. Market size and forecast, by Product Type
  - 7.2.5.2.3. Market size and forecast, by Biomaterial
  - 7.2.5.2.4. Market size and forecast, by Type
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Key market trends, growth factors and opportunities
  - 7.2.5.3.2. Market size and forecast, by Product Type
  - 7.2.5.3.3. Market size and forecast, by Biomaterial
  - 7.2.5.3.4. Market size and forecast, by Type
7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Product Type
- 7.3.3. Market size and forecast, by Biomaterial
- 7.3.4. Market size and forecast, by Type
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Key market trends, growth factors and opportunities
  - 7.3.5.1.2. Market size and forecast, by Product Type
  - 7.3.5.1.3. Market size and forecast, by Biomaterial
  - 7.3.5.1.4. Market size and forecast, by Type
  - 7.3.5.2. France
  - 7.3.5.2.1. Key market trends, growth factors and opportunities
  - 7.3.5.2.2. Market size and forecast, by Product Type
  - 7.3.5.2.3. Market size and forecast, by Biomaterial
  - 7.3.5.2.4. Market size and forecast, by Type
  - 7.3.5.3. UK
  - 7.3.5.3.1. Key market trends, growth factors and opportunities
  - 7.3.5.3.2. Market size and forecast, by Product Type
  - 7.3.5.3.3. Market size and forecast, by Biomaterial
  - 7.3.5.3.4. Market size and forecast, by Type
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Key market trends, growth factors and opportunities
  - 7.3.5.4.2. Market size and forecast, by Product Type
  - 7.3.5.4.3. Market size and forecast, by Biomaterial
  - 7.3.5.4.4. Market size and forecast, by Type
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Key market trends, growth factors and opportunities
  - 7.3.5.5.2. Market size and forecast, by Product Type
  - 7.3.5.5.3. Market size and forecast, by Biomaterial
  - 7.3.5.5.4. Market size and forecast, by Type
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Key market trends, growth factors and opportunities
  - 7.3.5.6.2. Market size and forecast, by Product Type
  - 7.3.5.6.3. Market size and forecast, by Biomaterial
  - 7.3.5.6.4. Market size and forecast, by Type
7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Product Type
- 7.4.3. Market size and forecast, by Biomaterial
- 7.4.4. Market size and forecast, by Type
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Key market trends, growth factors and opportunities
  - 7.4.5.1.2. Market size and forecast, by Product Type
  - 7.4.5.1.3. Market size and forecast, by Biomaterial
  - 7.4.5.1.4. Market size and forecast, by Type
  - 7.4.5.2. China
  - 7.4.5.2.1. Key market trends, growth factors and opportunities
  - 7.4.5.2.2. Market size and forecast, by Product Type
  - 7.4.5.2.3. Market size and forecast, by Biomaterial
  - 7.4.5.2.4. Market size and forecast, by Type
  - 7.4.5.3. Australia
  - 7.4.5.3.1. Key market trends, growth factors and opportunities
  - 7.4.5.3.2. Market size and forecast, by Product Type
  - 7.4.5.3.3. Market size and forecast, by Biomaterial
  - 7.4.5.3.4. Market size and forecast, by Type
  - 7.4.5.4. India
  - 7.4.5.4.1. Key market trends, growth factors and opportunities
  - 7.4.5.4.2. Market size and forecast, by Product Type
  - 7.4.5.4.3. Market size and forecast, by Biomaterial
  - 7.4.5.4.4. Market size and forecast, by Type
  - 7.4.5.5. South Korea
  - 7.4.5.5.1. Key market trends, growth factors and opportunities
  - 7.4.5.5.2. Market size and forecast, by Product Type
  - 7.4.5.5.3. Market size and forecast, by Biomaterial
  - 7.4.5.5.4. Market size and forecast, by Type
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Key market trends, growth factors and opportunities
  - 7.4.5.6.2. Market size and forecast, by Product Type
  - 7.4.5.6.3. Market size and forecast, by Biomaterial
  - 7.4.5.6.4. Market size and forecast, by Type
7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Product Type
- 7.5.3. Market size and forecast, by Biomaterial
- 7.5.4. Market size and forecast, by Type
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Key market trends, growth factors and opportunities
  - 7.5.5.1.2. Market size and forecast, by Product Type
  - 7.5.5.1.3. Market size and forecast, by Biomaterial
  - 7.5.5.1.4. Market size and forecast, by Type
  - 7.5.5.2. Saudi Arabia
  - 7.5.5.2.1. Key market trends, growth factors and opportunities
  - 7.5.5.2.2. Market size and forecast, by Product Type
  - 7.5.5.2.3. Market size and forecast, by Biomaterial
  - 7.5.5.2.4. Market size and forecast, by Type
  - 7.5.5.3. South Africa
  - 7.5.5.3.1. Key market trends, growth factors and opportunities
  - 7.5.5.3.2. Market size and forecast, by Product Type
  - 7.5.5.3.3. Market size and forecast, by Biomaterial
  - 7.5.5.3.4. Market size and forecast, by Type
  - 7.5.5.4. Rest of LAMEA
  - 7.5.5.4.1. Key market trends, growth factors and opportunities
  - 7.5.5.4.2. Market size and forecast, by Product Type
  - 7.5.5.4.3. Market size and forecast, by Biomaterial
  - 7.5.5.4.4. Market size and forecast, by Type

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. Arthrex, Inc.
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Key strategic moves and developments
9.2. Colfax Corporation (DJO GLOBAL LLC)
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
9.3. CONMED Corporation
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.3.7. Key strategic moves and developments
9.4. Globus Medical, Inc.
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.4.7. Key strategic moves and developments
9.5. Johnson & Johnson
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.5.7. Key strategic moves and developments
9.6. Medtronic plc
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.6.7. Key strategic moves and developments
9.7. NuVasive Inc.
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
- 9.7.7. Key strategic moves and developments
9.8. Smith & Nephew plc
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
- 9.8.7. Key strategic moves and developments
9.9. Stryker Corporation
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.9.7. Key strategic moves and developments
9.10. Zimmer Biomet Holdings Inc.
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- 9.10.7. Key strategic moves and developments